美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SAB Biotherapeutics, Inc. Warrant

0.0426

+0.00276.77%

成交量：5,304.00

成交額：178.17

市值：44.35萬

市盈率：-0.02

高：0.0427

開：0.0297

低：0.0297

收：0.0399

52周最高：0.1800

52周最低：0.0205

股本：1,041.11萬

流通股本：1,041.11萬

量比：14.82

換手率：0.05%

股息：- -

股息率：- -

每股收益(TTM):-2.8053

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

SAB Bio的SAB-142三期T1d治療臨牀試驗首例患者已用藥

SAB Bio宣佈SAB-142在3期T1d治療中的1期研究確認性臨牀結果積極

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股價拉升20.16% 市值漲18.33萬美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盤中異動急速跳水13.35%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SABSW"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SABSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SABSW\",,,,,undefined,":{"symbol":"SABSW","market":"US","secType":"STK","nameCN":"SAB Biotherapeutics, Inc. Warrant","latestPrice":0.0426,"timestamp":1770843600000,"preClose":0.0399,"halted":0,"volume":5304,"delay":0,"changeRate":0.06766917293233085,"floatShares":10411067,"shares":10411067,"eps":-2.8053,"marketStatus":"盤前交易","change":0.0027,"latestTime":"02-12 05:07:42 EST","open":0.0297,"high":0.0427,"low":0.0297,"amount":178.1654,"amplitude":0.325815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.8053,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770906600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0345,"volumeRatio":14.815637905809583},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SABSW\",,,,,undefined,":{"symbol":"SABSW","floatShares":10411067,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":14.815637905809583,"shares":10411067,"dividePrice":0,"high":0.0427,"amplitude":0.325815,"preClose":0.0399,"low":0.0297,"week52Low":0.0205,"pbRate":"--","week52High":0.18,"institutionHeld":0,"latestPrice":0.0426,"eps":-2.8053,"divideRate":0,"volume":5304,"delay":0,"ttmEps":-2.8053,"open":0.0297,"prevYearClose":0.0312,"prevWeekClose":0.043,"prevMonthClose":0.038,"prevQuarterClose":0.0312,"fiveDayClose":0.04,"twentyDayClose":0.0297,"sixtyDayClose":0.0332},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SABSW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-10","symbol":"SABSW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1660104000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-03-29","symbol":"SABSW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1648526400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SABSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SABSW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SABSW\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193156416","title":"SAB Bio的SAB-142三期T1d治療臨牀試驗首例患者已用藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1193156416","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193156416?lang=zh_tw&edition=fundamental","pubTime":"2025-12-18 21:04","pubTimestamp":1766063048,"startTime":"0","endTime":"0","summary":"SAB Bio的SAB-142三期T1d治疗临床试验首例患者已用药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SABSW","BK4139","SABS"],"gpt_icon":0},{"id":"1162504708","title":"SAB Bio宣佈SAB-142在3期T1d治療中的1期研究確認性臨牀結果積極","url":"https://stock-news.laohu8.com/highlight/detail?id=1162504708","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162504708?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 21:01","pubTimestamp":1765976504,"startTime":"0","endTime":"0","summary":"SAB Bio宣布SAB-142在3期T1d治疗中的1期研究确认性临床结果积极","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SABS","SABSW"],"gpt_icon":0},{"id":"2584907900","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股價拉升20.16% 市值漲18.33萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584907900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584907900?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:10","pubTimestamp":1763568603,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日00时10分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价快速上涨20.16%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.90%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120001003a704c13b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120001003a704c13b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2584953285","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盤中異動 急速跳水13.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584953285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584953285?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 04:32","pubTimestamp":1763411521,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日04时32分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价急速下跌13.35%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为1.22%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118043202a4a862fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118043202a4a862fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SABSW\",params:#limit:6,delay:false,,,undefined,":[]}}